Cargando…

Innate immunity, cytokine storm, and inflammatory cell death in COVID-19

The innate immune system serves as the first line of defense against invading pathogens; however, dysregulated innate immune responses can induce aberrant inflammation that is detrimental to the host. Therefore, careful innate immune regulation is critical during infections. The coronavirus disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Karki, Rajendra, Kanneganti, Thirumala-Devi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682745/
https://www.ncbi.nlm.nih.gov/pubmed/36419185
http://dx.doi.org/10.1186/s12967-022-03767-z
_version_ 1784834920528478208
author Karki, Rajendra
Kanneganti, Thirumala-Devi
author_facet Karki, Rajendra
Kanneganti, Thirumala-Devi
author_sort Karki, Rajendra
collection PubMed
description The innate immune system serves as the first line of defense against invading pathogens; however, dysregulated innate immune responses can induce aberrant inflammation that is detrimental to the host. Therefore, careful innate immune regulation is critical during infections. The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in global morbidity and mortality as well as socio-economic stresses. Innate immune sensing of SARS-CoV-2 by multiple host cell pattern recognition receptors leads to the production of various pro-inflammatory cytokines and the induction of inflammatory cell death. These processes can contribute to cytokine storm, tissue damage, and acute respiratory distress syndrome. Here, we discuss the sensing of SARS-CoV-2 to induce innate immune activation and the contribution of this innate immune signaling in the development and severity of COVID-19. In addition, we provide a conceptual framework for innate immunity driving cytokine storm and organ damage in patients with severe COVID-19. A better understanding of the molecular mechanisms regulated by innate immunity is needed for the development of targeted modalities that can improve patient outcomes by mitigating severe disease.
format Online
Article
Text
id pubmed-9682745
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96827452022-11-24 Innate immunity, cytokine storm, and inflammatory cell death in COVID-19 Karki, Rajendra Kanneganti, Thirumala-Devi J Transl Med Review The innate immune system serves as the first line of defense against invading pathogens; however, dysregulated innate immune responses can induce aberrant inflammation that is detrimental to the host. Therefore, careful innate immune regulation is critical during infections. The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in global morbidity and mortality as well as socio-economic stresses. Innate immune sensing of SARS-CoV-2 by multiple host cell pattern recognition receptors leads to the production of various pro-inflammatory cytokines and the induction of inflammatory cell death. These processes can contribute to cytokine storm, tissue damage, and acute respiratory distress syndrome. Here, we discuss the sensing of SARS-CoV-2 to induce innate immune activation and the contribution of this innate immune signaling in the development and severity of COVID-19. In addition, we provide a conceptual framework for innate immunity driving cytokine storm and organ damage in patients with severe COVID-19. A better understanding of the molecular mechanisms regulated by innate immunity is needed for the development of targeted modalities that can improve patient outcomes by mitigating severe disease. BioMed Central 2022-11-22 /pmc/articles/PMC9682745/ /pubmed/36419185 http://dx.doi.org/10.1186/s12967-022-03767-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Karki, Rajendra
Kanneganti, Thirumala-Devi
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
title Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
title_full Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
title_fullStr Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
title_full_unstemmed Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
title_short Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
title_sort innate immunity, cytokine storm, and inflammatory cell death in covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682745/
https://www.ncbi.nlm.nih.gov/pubmed/36419185
http://dx.doi.org/10.1186/s12967-022-03767-z
work_keys_str_mv AT karkirajendra innateimmunitycytokinestormandinflammatorycelldeathincovid19
AT kannegantithirumaladevi innateimmunitycytokinestormandinflammatorycelldeathincovid19